How Clinical Trials Inform Treatment Selection in Early-Stage HR+ Breast Cancer

A brief review of prevalent clinical trials in the early-stage HR+ breast cancer paradigm and how they help to inform treatment decision-making.

Related Videos
Susan Domchek, MD, FASCO
Expert on CSCC
Expert on CSCC
Experts on BTC
Experts on BTC
Ruth M. O’Regan, MD, professor, chair, Charles Ayrault Dewey Professorship of Medicine, Department of Medicine, the University of Rochester, physician-in-chief, Strong Memorial Hospital, associate director, Education and Mentoring, the Wilmot Cancer Institute at University of Rochester,
Expert on AML
Expert on AML
Experts on CRC
Related Content